Induction immunochemotherapy leads to higher conversion surgery rates and improved overall survival compared to induction chemotherapy in patients with initially unresectable esophageal squamous cell carcinoma. The immunochemotherapy cohort exhibited a notably superior conversion rate and higher pathological complete response rates, resulting in significantly better overall survival outcomes. This study suggests that immunochemotherapy alongside conversion surgery may offer a more effective treatment approach for patients with unresectable esophageal squamous cell carcinoma.
Journal Article by Huang S, Wang S (…) Qiao G et 7 al. in Ann Surg Oncol
© 2024. Society of Surgical Oncology.